首页> 美国卫生研究院文献>Journal of the Canadian Association of Gastroenterology >A10 TR1 CELL-BASED THERAPY FOR INFLAMMATORY ILEITIS IN SHIP-/- MICE
【2h】

A10 TR1 CELL-BASED THERAPY FOR INFLAMMATORY ILEITIS IN SHIP-/- MICE

机译:基于A10 TR1细胞的船舶炎症性白血病的治疗

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Crohn’s disease (CD), a form of inflammatory bowel disease (IBD), is characterized by chronic inflammation that can occur anywhere along the gastrointestinal (GI) tract, but commonly involves the distal portion of the ileum. Src homology 2 (SH2) domain-containing inositol polyphosphate 5-phosphatase 1 (SHIP) is a hematopoietic-specific regulator of secondary signals generated by the PI3K pathway and regulates immune activation. SHIP mice, at 6–8 weeks of age, spontaneously develop inflammatory ileitis due to myeloid proliferation, a lack of T cells, and an increase in IL-1β.
机译:克罗恩病(CD)是一种炎症性肠病(IBD),其特征是慢性炎症可以在胃肠道(GI)的任何地方发生,但通常累及回肠的远端。包含Src同源性2(SH2)域的肌醇多磷酸5磷酸酶1(SHIP)是PI3K途径产生的次级信号的造血特异性调节剂,并调节免疫激活。 SHIP小鼠在6–8周龄时,由于髓系增殖,T细胞缺乏和IL-1β升高而自发发展为炎症性回肠炎。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号